TrialBMC cancer2018

Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy.

Hiroshi Saeki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.